Show options

Switzerland

Pharma and Health Care

Frank Scherrer

Frank Scherrer

Frank Scherrer works primarily in the pharmaceutical and health sector. He mainly advises and represents pharmaceutical companies with regard to drug approvals, permits, reimbursements, advertising and sales, the drafting of all types of contracts, data protection and product liability. Further areas of specialization include antitrust and competition law, labor law, and data law. He also advises clients on questions relating to medical devices and human research. He represents his clients in contract negotiations, as well as in official and judicial proceedings. He heads the Life Sciences Team at Wenger Vieli. “Contributing to the development of new therapies and solutions in the life sciences by means of targeted advice is what motivates me. I particularly value the independence and diverse challenges characteristic of our work.”
Beat Speck

Beat Speck

Beat Speck is a deal enabler for private, cross-border M&A transactions, often in the private equity or venture capital context, but also regularly in industry (especially within the energy, IT, telecommunications, and entertainment industries). This also includes exits through IPOs, joint ventures, and reorganizations. “Dealing on a daily basis with not only legal, but also economic, tax-related, physical, and psychological challenges fascinates me – the more so the longer I’m in this profession. The focus is on working together with the customer to find solutions in order to make a transaction possible, and not looking for reasons why it won’t work. It's not always easy, but with a little persistence, creativity, and perseverance, you can usually achieve persuasive results.”
Daniel P Oehri

Daniel P Oehri

Daniel Oehri’s practice focuses on general corporate and contract law, restructuring and bankruptcy law, as well as capital markets and stock exchange law. He thus regularly advises clients in connection with debt and equity financings, restructurings, (distressed) M&A transactions, joint ventures and takeover offers, and further legal issues surrounding the clients’ daily business activities. Daniel Oehri also represents his clients before courts, state authorities, and self-governing bodies. “What I cherish most about my profession is that I always have the opportunity to work with interesting personalities from a wide variety of industries, on very different and exciting projects.”

Team Services

We mainly advise pharmaceutical, biotech and medical device companies and also service other players in the healthcare sector in a broad range of legal matters.

Our focus is on marketing authorization and market access, reimbursement by health insurance, governmental licenses, advertising, manufacturing and distribution, collaboration with doctors and hospitals, compliance, clinical trials, licensing of intellectual property rights, competition and antitrust law, eHealth, data protection as well as product liability. Thanks to our profound knowledge of the Swiss health care system and the practice of the authorities and the courts, we advise our clients in a targeted and efficient manner.

Our expertise covers specifically:

- Drafting and negotiating distribution, cooperation, licensing, clinical trial, advisory, service, sponsorship and support agreements
- Advice and representation in dealings with Swissmedic and the FOPH (Swiss Federal Office of Public Health) in all therapeutic products legislation matters
- Appeal proceedings
- Review of advertising and cooperation with professionals for compliance with Swiss legislation, the Swiss Pharma Code and the Pharma Cooperation Code (Compliance)
- Representation in administrative and administrative criminal proceedings
- Review of Standard Operating Procedures
- Due diligence reviews and transactions
- Advice on human research law
- Drafting and negotiating clinical trial agreements
- Representation in unfair competition proceedings
- Representation in product liability proceedings
- Advice on data protection, information technology, new media and eHealth projects